IGF-1 LR3.
A long-acting IGF-1 analog for advanced body recomposition and recovery protocols.
Pricing is shown after your free assessment, before you commit.
Free to start. No card required.
Reviewed by Lumora clinical team (Licensed provider network)Mixed evidenceSource: Client-approved product catalog; provider review required
Evidence, regulatory status, and fit vary by medication, formulation, route, and individual history.
Is this for you?
This is for you if
- Patients wanting faster muscle growth and recovery
- Patients who recover slowly from training
- Patients pursuing lean-mass and body-recomposition goals
- Patients already training consistently and seeking advanced support
This isn't for you if
Possible side effects include hypoglycemia, fluid retention, or injection-site reactions. Not appropriate during pregnancy, with active or prior cancer, or with uncontrolled diabetes. Specialist supervision required.
IGF-1 LR3
IGF-1 LR3 is a long-acting form of Insulin-like Growth Factor 1 — the growth factor responsible for muscle repair and tissue growth. It is a more advanced peptide used in body-recomposition and recovery protocols under close provider supervision.
Mechanism and fit.
IGF-1 LR3 extends the activity of natural IGF-1, increasing muscle protein synthesis, supporting satellite cell activation, and enhancing recovery. It also supports fat metabolism and overall training adaptation.
Who this is typically for.
- Patients wanting faster muscle growth and recovery
- Patients who recover slowly from training
- Patients pursuing lean-mass and body-recomposition goals
- Patients already training consistently and seeking advanced support
What patients
most often ask.
Is IGF-1 LR3 for beginners?
No. IGF-1 LR3 is an advanced peptide reserved for patients already training consistently, with appropriate baseline labs, and under close provider supervision.
Is it cycled?
Yes — typically 4–6 weeks per cycle, not continuous.
Who this is typically for.
These are common fit patterns from the approved catalog. Your provider determines whether treatment is appropriate.
- <ul><li>Patients wanting faster muscle growth and recovery</li><li>Patients who recover slowly from training</li><li>Patients pursuing lean-mass and body-recomposition goals</li><li>Patients already training consistently and seeking advanced support</li></ul>
How this option
is evaluated.
The plan is provider-determined after reviewing your assessment and safety factors.
- DosingProvider-directed daily or post-workout administration.
- Typical duration4–6 week cycles (not continuous).
- Safety and eligibilityYour provider reviews contraindications, medication interactions, goals, and safety factors before prescribing.
- A licensed provider reviews your assessment before any treatment is recommended.
- You see full pricing - visit fees, medication, labs, follow-up - before you commit.
- Your plan can be adjusted, paused, or stopped based on response and safety. Your clinician is reachable - not a chatbot.
- Compounded medications are not FDA-approved and are dispensed only when prescribed by a licensed provider.
Start with
provider review.
If you are considering IGF-1 LR3, the first step is a free assessment. A provider determines whether it fits your goals and medical history.
A provider determines whether treatment is clinically appropriate.